These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 9617660

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ.
    J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613
    [Abstract] [Full Text] [Related]

  • 3. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ, Kleinebenne A.
    Herz; 1985 Apr 01; 10(2):91-101. PubMed ID: 2580767
    [Abstract] [Full Text] [Related]

  • 4. [Sudden death in hypertrophic obstructive and non-obstructive cardiomyopathy: can it be prevented?].
    Grobéty M, Schlaepfer J, Kappenberger L, Fromer M.
    Schweiz Med Wochenschr; 1997 Apr 12; 127(15):623-30. PubMed ID: 9198888
    [Abstract] [Full Text] [Related]

  • 5. [The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy].
    Göktekin O, Ritsushi K, Matsumoto K, Hiroshi M.
    Anadolu Kardiyol Derg; 2002 Sep 12; 2(3):226-30. PubMed ID: 12223331
    [Abstract] [Full Text] [Related]

  • 6. Ambulatory monitoring of the sudden death of an adolescent with hypertrophic cardiomyopathy.
    Gardin LL, Nanton MA, Hanna BD.
    Can J Cardiol; 1994 Jun 12; 10(5):548-50. PubMed ID: 8012885
    [Abstract] [Full Text] [Related]

  • 7. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G, Elliott PM, Pacileo G, Sarubbi B, Thaman R, Calabrò P, Vergara P, Iacomino M, Russo MG, Calabrò R.
    J Cardiovasc Med (Hagerstown); 2006 Sep 12; 7(9):711-3. PubMed ID: 16932087
    [Abstract] [Full Text] [Related]

  • 8. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G, Ciaccheri M, Cecchi F, Troiani V, Nannini M, Marconi P, Olivotto J, Montereggi A, Dolara A.
    G Ital Cardiol; 1999 May 12; 29(5):514-23. PubMed ID: 10367218
    [Abstract] [Full Text] [Related]

  • 9. Sudden cardiac death in hypertrophic cardiomyopathy.
    Maron BJ, Fananapazir L.
    Circulation; 1992 Jan 12; 85(1 Suppl):I57-63. PubMed ID: 1728506
    [Abstract] [Full Text] [Related]

  • 10. Sustained arrhythmias in hypertrophic obstructive cardiomyopathy.
    Kowey PR, Eisenberg R, Engel TR.
    N Engl J Med; 1984 Jun 14; 310(24):1566-9. PubMed ID: 6539421
    [Abstract] [Full Text] [Related]

  • 11. Failure of amiodarone to prevent ventricular fibrillation (sudden death) in hypertrophic cardiomyopathy.
    Mercereau D, Kubac G, Klinke WP.
    Can J Cardiol; 1989 Mar 14; 5(2):77-80. PubMed ID: 2706577
    [Abstract] [Full Text] [Related]

  • 12. [Ambulatory electrocardiographic recording (Holter) at the moment of a sudden death event].
    Dorantes-Sánchez M, Castro-Hevia J, Fayad-Rodríguez Y, Tornés-Bárzaga F, Zayas-Molina R.
    Arch Cardiol Mex; 2009 Mar 14; 79(2):127-31. PubMed ID: 19722383
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population.
    Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ.
    J Am Coll Cardiol; 1995 Nov 15; 26(6):1529-36. PubMed ID: 7594081
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Holter monitoring and long-term prognosis in hypertrophic cardiomyopathy.
    Kawasaki T, Sakai C, Harimoto K, Yamano M, Miki S, Kamitani T, Sugihara H.
    Cardiology; 2012 Nov 15; 122(1):44-54. PubMed ID: 22722267
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.